Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Risankizumab	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[4] 37, 96, 97, 271 💬
2	Risankizumab (genetical recombination)	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[1] 97 💬
3	Risankizumab 10 mg/ml	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[1] 96 💬
4	Risankizumab 180 mg sc	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[1] 96 💬
5	Risankizumab 600 mg iv	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[1] 96 💬
6	Risankizumab 90 mg/ml	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[1] 96 💬
7	Risankizumab iv	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[2] 96, 97 💬
8	Risankizumab sc	Risankizumab	[1] D11052 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	[2] 96, 97 💬